Community Pharmacy Practice in Italy during the COVID-19 (SARS-CoV-2) Pandemic: Regulatory Changes and a Cross-Sectional Analysis of Seroprevalence.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
26 02 2021
Historique:
received: 21 01 2021
revised: 19 02 2021
accepted: 22 02 2021
entrez: 3 3 2021
pubmed: 4 3 2021
medline: 6 3 2021
Statut: epublish

Résumé

Pharmacists in the community and the essential requirement to safeguard their own health have become fundamental since the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The aims of this paper were (I) to analyze the directives provided to pharmacists in 2020 regarding preventative safety measures to be adopted; (II) to determine the number of pharmacists who came into contact with SARS-CoV-2 in North-West Italy and relate this to the adopted preventative measures. The first aim was pursued by conducting a bibliographic research, consulting the principal regulatory sources. The second one was achieved with an observational study by administering a questionnaire and performing a serological test. The various protection measures imposed by national and regional legislation were analyzed. Two hundred and eighty-six pharmacists (about 8% of the invited ones) responded to the survey. Ten pharmacists reported a positive result to the serological test. Of the subjects who presented a positive result, three declared that they had not used a hand sanitizer, while two stated that they had not scheduled the cleaning and decontamination of surfaces. Two interviewees had not set up a system of quota restrictions on admissions. In four cases, a certified cleaning company had decontaminated the premises. The results of our study show that during the coronavirus disease 2019 (COVID-19) pandemic, the most pressing challenge for community pharmacists has been the protection of staff and clients inside the pharmacy; the challenge to be faced in the near future will probably be the management of new responsibilities.

Identifiants

pubmed: 33652711
pii: ijerph18052302
doi: 10.3390/ijerph18052302
pmc: PMC7967686
pii:
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Références

Res Social Adm Pharm. 2021 Feb;17(2):456-459
pubmed: 32387229
Clin Microbiol Infect. 2021 Feb;27(2):289.e1-289.e4
pubmed: 33031947
Cochrane Database Syst Rev. 2020 Jun 25;6:CD013652
pubmed: 32584464
Int J Clin Pharm. 2021 Jan 15;:
pubmed: 33449247
Res Social Adm Pharm. 2021 Jan;17(1):1819-1824
pubmed: 32249102
Microorganisms. 2020 Dec 28;9(1):
pubmed: 33379279
Pharmacy (Basel). 2020 Aug 07;8(3):
pubmed: 32784696
Vaccine. 2016 Nov 11;34(47):5708-5723
pubmed: 27765379
Integr Pharm Res Pract. 2015 Jul 01;4:67-77
pubmed: 29354521
Ir J Psychol Med. 2020 Sep;37(3):198-203
pubmed: 32434603
Vaccine. 2016 Nov 4;34(46):5643-5648
pubmed: 27686834
Res Social Adm Pharm. 2021 Jan;17(1):1845-1852
pubmed: 33317763
Vaccines (Basel). 2020 Sep 16;8(3):
pubmed: 32947988

Auteurs

Francesca Baratta (F)

Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy.

Giulio Mario Visentin (GM)

Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy.

Lorenzo Ravetto Enri (L)

Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy.

Marco Parente (M)

Turin Pharmacy Owners Association "Federfarma", Via Sant'Anselmo14, 10125 Turin, Italy.

Irene Pignata (I)

Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy.

Francesco Venuti (F)

Department of Medical Sciences, Unit of Infectious Diseases, University of Turin, C.so Svizzera, 164, 10149 Turin, Italy.

Giovanni Di Perri (G)

Department of Medical Sciences, Unit of Infectious Diseases, University of Turin, C.so Svizzera, 164, 10149 Turin, Italy.

Paola Brusa (P)

Department of Drug Science and Technology, University of Turin, Via Pietro Giuria 9, 10125 Turin, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH